Actively Recruiting
Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS)
Led by Kuopio University Hospital · Updated on 2024-10-04
78
Participants Needed
1
Research Sites
225 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if transcranial alternating current stimulation can shorten the duration of delirium in intensive care setting. The main question it aims to answer: * Is it possible to shorten the duration of delirium with transcranial alternating current stimulation? Researchers will compare experimental treatment to sham. Participants will receive experimental or sham treatment on maximum of two days depending on their delirium status. Duration of delirium is recorded and reported as "days alive and free of delirium".
CONDITIONS
Official Title
Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Delirium in intensive care lasting more than 24 hours, defined by an ICDSC score of 4 or more and a RASS score of -1 or more
You will not qualify if you...
- Under 18 years of age
- Pregnancy
- Delirium tremens
- Epilepsy or history of seizures before first trial intervention
- Active psychotic disease
- Infection of the central nervous system
- Acute intoxication
- Traumatic brain injury
- Stroke
- Intracranial bleeding
- Implanted electronic devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kuopio University Hospital
Kuopio, Finland
Actively Recruiting
Research Team
V
Ville Ihalainen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here